What the insulin cap means for employers’ premiums | EBA
The three biggest insulin drug manufacturers have recently capped their insulin prices, with Eli Lilly starting the trend in March after it limited its out-of-pocket cost of insulin to $35 per As part of the Inflation Reduction Act, pharmaceutical…
Read More